SYNTHESIS OF OPTICALLY PURE OXYGENATED CYCLOPENTANOIDS
Project Number5R01CA037806-02
Contact PI/Project LeaderJOHNSON, CARL RANDOLPH
Awardee OrganizationWAYNE STATE UNIVERSITY
Description
Abstract Text
The specific aims of the research proposed are:
(1) The development of an efficient method for the enantioconvergent
production of an optically pure intermediate (a protected
4,5-dihydroxy-2-cyclopenten-1-one) of broad utility in the synthesis of a
variety of biologically active oxygenated cyclopenanoids.
(2) Optimization of the utilizaton of this intermediate in the development
of a synthesis of the antitumor carbocyclic nucleoside, (-)-neplanocin A,
by exploration of a number of synthetic pathways.
(3) Utilization of the intermediate developed in (1) and the chemistry
explored in (2) to synthesize a number of neplanocin A analogues (in which
the base component has been altered) for screening as antitumor and/or
antiviral agents.
(4) Conversion of the intermediate noted in (1) into an optically pure form
of "(-)-carbocyclic ribose" and conversion of this to the antibiotic
(-)-aristeromycin.
(5) Demonstration of the utility of the intermediate noted in (1) in the
synthesis of an optically pure prostaglandin and other biologically
interesting natural products.
(6) Synthesis of simplified prostanoid targets which contain enone or
latent enont functionality for screening in an effort to establish
structure/activity relationships, particularly as DNA polymerase
inhibitors, for compounds of this class as antineoplastic agents.
Public Health Relevance Statement
Data not available.
NIH Spending Category
No NIH Spending Category available.
Project Terms
DNA directed DNA polymeraseantiviral agentscyclopentanedrug design /synthesis /productionopticsprostaglandins
No Sub Projects information available for 5R01CA037806-02
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01CA037806-02
Patents
No Patents information available for 5R01CA037806-02
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01CA037806-02
Clinical Studies
No Clinical Studies information available for 5R01CA037806-02
News and More
Related News Releases
No news release information available for 5R01CA037806-02
History
No Historical information available for 5R01CA037806-02
Similar Projects
No Similar Projects information available for 5R01CA037806-02